Biggest News Aggregation in the World
📰 Previously Completed Phase News

Previously Completed Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Previously Completed Phase. Real-time updates on events, politics, business and more.

Cassava Sciences Announces Positive End-of-Phase 2 Meeting with FDA and Outlines Pivotal Phase 3 Program for Simufilam in Alzheimer's Disease Nasdaq:SAVA

Support a New Drug Application Filing for Simufilam in Alzheimer’s disease - - Agreement Reached to Use ADAS-Cog as Co-Primary Efficacy Endpoint - - Pivotal Phase 3 Program Remains On-track to be Initiated 2 nd Half 2021 - AUSTIN, Texas, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company developing product candidates for Alzheimer’s disease, today announced the successful completion of an End-of-Phase 2 (EOP2) meeting with the U.S. Food and ...
United States Jim Kupiec Remi Barbier Cassava Sciences Inc Clinical Development Officer Agreement Reached To Use As Co

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science